UNSPSC 51241223: Calcipotriene or calcipotriol

This classification denotes an anti-psoriatic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 143NQ3779B. European Medicines Agency schedules Calcipotriol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06046MIG. Calcipotriene generally arises in the molecular formula C27H40O3. The term CALCIPOTRIENE is an International Non-Proprietary Name or INN. Calcipotriene or calcipotriol bears US NLM identifiers UMLS ID C0065767 and NCI Concept Code C28900.

SMILES: CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C.

UNSPSC 51241223 Calcipotriene or calcipotriol is a Commodity code covering a specific pharmaceutical ingredient used in dermatological treatments, but recent state and local procurement activity under this code shows minimal relevant purchasing. The single recent solicitation posted by the City of Tampa under this code—ITB 25-P-00157 for medical aid supplies—does not reflect calcipotriene procurement; instead, it covers a broad array of first-aid consumables including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first-aid kits, and emergency blankets for the Fire Rescue Department. This mismatch suggests the code may be incorrectly tagged in the City of Tampa's procurement system or applied to a general medical supplies category rather than the specialty pharmaceutical ingredient the UNSPSC code nominally describes.

The City of Tampa represents the primary recent issuing body visible under this code, with a $100,000 budget for the medical supplies procurement. The ITB closed April 9, 2025, and includes local business set-asides for City-certified Small Local Business Enterprises with a 5% bid discount (capped at $10,000) and Underutilized Woman and Minority Owned Business Enterprises with a 5% discount (capped at $20,000). The geographic scope reflects only Florida activity in the recent-opportunities block. The absence of additional calcipotriene-specific solicitations across state and local jurisdictions suggests either low demand for this ingredient as a standalone procurement item or systematic miscoding of dermatological pharmaceutical purchases elsewhere in the UNSPSC taxonomy.